BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31210014)

  • 61. Estrogen receptor alpha (ERS1) SNPs c454-397T>C (PvuII) and c454-351A>G (XbaI) are risk biomarkers for breast cancer development.
    Madeira KP; Daltoé RD; Sirtoli GM; Carvalho AA; Rangel LB; Silva IV
    Mol Biol Rep; 2014 Aug; 41(8):5459-66. PubMed ID: 24928087
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
    Hashemi M; Sanaei S; Hashemi SM; Eskandari E; Bahari G
    Clin Breast Cancer; 2018 Oct; 18(5):e883-e891. PubMed ID: 29439926
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Polymorphisms in DNA Repair Gene XRCC3 and Susceptibility to Breast Cancer in Saudi Females.
    Ali AM; AbdulKareem H; Al Anazi M; Reddy Parine N; Shaik JP; Alamri A; Ali Khan Pathan A; Warsy A
    Biomed Res Int; 2016; 2016():8721052. PubMed ID: 26881229
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of the IL-10 gene rs1800872 (-592 C>A) polymorphism with breast cancer in a Mexican population.
    Patricia Gallegos-Arreola M; Zúñiga González GM; Figuera LE; Puebla Pérez AM; Delgado Saucedo JI
    J BUON; 2019; 24(6):2369-2376. PubMed ID: 31983108
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Influence of rs1859168 Polymorphism on Serum Expression of HOTTIP and Its Target miR-615-3p in Egyptian Patients with Breast Cancer.
    Abdelaleem OO; Shaker OG; AbdelHafez MN; Abdelghaffar NK; Eid HM; Zaidan M; Khalefa AA; Ahmed NA; Hemeda NF; Zaki OM; Awaji AAA; Mohammed SR
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34069089
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of Lung Function-Related Genes and
    Yamada H; Hida N; Masuko H; Sakamoto T; Hizawa N
    COPD; 2020 Feb; 17(1):59-64. PubMed ID: 31910693
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SNP rs2071095 in LincRNA H19 is associated with breast cancer risk.
    Cui P; Zhao Y; Chu X; He N; Zheng H; Han J; Song F; Chen K
    Breast Cancer Res Treat; 2018 Aug; 171(1):161-171. PubMed ID: 29737472
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Matrix metalloproteinase-2 C(-1306)T promoter polymorphism and breast cancer risk in the Saudi population.
    Saeed HM; Alanazi MS; Alshahrani O; Parine NR; Alabdulkarim HA; Shalaby MA
    Acta Biochim Pol; 2013; 60(3):405-9. PubMed ID: 24051440
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The IFN-Ɣ + 874 A/T polymorphism is associated with malignant breast cancer in a population from the southwest of Iran.
    Rezaeean H; Kaydani GA; Saki N; Razmjoo S; Labibzadeh M; Yaghooti H
    BMC Res Notes; 2021 Apr; 14(1):147. PubMed ID: 33879226
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
    Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L
    Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Breast cancer-related single-nucleotide polymorphism and their risk contribution in Mexican women.
    Figueroa-González G; Arellano-Gutiérrez CV; Cortés H; Leyva-Gómez G; Carmen MG; Bustamante-Montes LP; Rodríguez-Morales M; López-Reyes I; Alcaraz-Estrada SL; Sandoval-Basilio J; Quintas-Granados LI; Reyes-Hernández OD
    J Cancer Res Ther; 2020; 16(6):1279-1286. PubMed ID: 33342785
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients.
    Tulsyan S; Agarwal G; Lal P; Mittal B
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1065-78. PubMed ID: 25223935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predictive role of single nucleotide polymorphism (rs11614913) in the development of breast cancer in Pakistani population.
    Ahmad M; Shah AA
    Per Med; 2020 May; 17(3):213-227. PubMed ID: 32320336
    [No Abstract]   [Full Text] [Related]  

  • 74. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
    Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
    Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
    Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival.
    Meshkat M; Tanha HM; Naeini MM; Ghaedi K; Sanati MH; Meshkat M; Bagheri F
    Cancer Biomark; 2016 Jul; 17(2):213-22. PubMed ID: 27434289
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
    Li X; Zhang R; Liu Z; Li S; Xu H
    Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.
    Zidi I; Dziri O; Zidi N; Sebai R; Boujelebene N; Ben Hassine A; Ben Yahia H; Laaribi AB; Babay W; Rifi H; Mezlini A; Chelbi H
    Immunol Res; 2016 Aug; 64(4):961-8. PubMed ID: 26754763
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of Interaction Between PPAR Alpha and PPAR Gamma on Breast Cancer Risk in the Chinese Han Population.
    Lianggeng X; Baiwu L; Maoshu B; Jiming L; Youshan L
    Clin Breast Cancer; 2017 Aug; 17(5):336-340. PubMed ID: 28669518
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of MIR31HG polymorphisms on risk of breast cancer in Chinese women.
    Wei Y; Wang X; Zhang Z; Zhao C; Chang Y; Bian Z; Zhao X
    Int J Clin Oncol; 2023 May; 28(5):664-679. PubMed ID: 36884100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.